Welcome to our dedicated page for Limbach Holdings news (Ticker: $LMB), a resource for investors and traders seeking the latest updates and insights on Limbach Holdings stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Limbach Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Limbach Holdings's position in the market.
Limbach Holdings, Inc. (Nasdaq: LMB) reported first quarter 2024 results, showing a 26.5% increase in quarterly revenue from Owner Direct Relationships (ODR) segment. ODR accounted for 62.4% of revenue and 71.3% of consolidated gross profit. The company achieved a record quarterly consolidated gross margin of 26.1%, with quarterly net income up 153.5% to $7.6 million. Adjusted EBITDA also rose by 35.4% year-over-year. Limbach's management is optimistic about the growth potential of the ODR business segment, increasing Adjusted EBITDA guidance to $51-55 million for the year and projecting a full-year Adjusted EBITDA Margin of 9.6% to 10.8% based on total revenue of $510-530 million.